All Activity

Thanks a lot pertaining to putting up a real wonderful content! I ran across your web site ideal for our requires. Its content has amazing along with valuable blogposts. Carry on the excellent operate! 경마 커뮤니티

Navigating Escorts Near Itc Maurya Hotel Chanakyapuri options requires understanding local regulations and cultural norms. Some cities have established red-light districts near hotels, while others operate more discreetly. Researching your destination beforehand prevents legal complications. Many travelers prefer pre-booking through verified agencies that handle all arrangements. This approach eliminates awkward hotel lobby encounters and ensures your companion arrives at a predetermined time for maximum convenience.

Struggling to translate academic papers without breaking formulas or tables? PDF Translator handles scanned PDFs and research documents while keeping the original layout intact—a solid option for technical work.

Tired of retyping tables from screenshots? Extract Table Trom Image lets you upload a photo and get an editable grid, even for messy real-world tables.

Josh Turek, the Democratic nominee in a U.S. Senate race in Iowa this year, says it’s time to federally legalize, regulate and tax marijuana. The candidate, currently a state representative, told voters at an Iowa State University football tailgate that he thinks cannabis’s longtime restrictive Schedule I status is “ridiculous.” Turek told one man that he liked a cannabis leaf hat he was wearing. That prompted a woman to tell the Senate candidate that he should “fix” federal marijuana laws, adding that she has “so much pain” and “would like to be able to take gummies at night.” Turek, who was born with spina bifida and is in a wheelchair, said he has “dealt with so many individuals with disabilities” and that cannabis is “one of the few ways that they see relief from their spasms.” He suggested that marijuana isn’t harmful enough to be prohibited “in the grand scheme of things, when you’re looking at the health implications from tobacco or from alcohol.” “Or opioids,” the woman voter chimed in. “I do not want to take opioids.” “Absolutely,” Turek replied. Policymakers will “always reach out for Big Pharma,” he said, but not for “anything natural.” “I would love to be able to address that federal level,” the candidate said. “I think it should be legalized and regulated, and let’s tax it. You’ve seen it with other states.” In 2023, Turek cosponsored a bill in the Iowa House of Representatives to legalize adult-use marijuana and expand the state’s current medical cannabis program by allowing doctors to recommend it for any medical condition they see fit. Turek’s opponent for the Senate seat, U.S. Rep. Ashley Hinson (R), voted against a bill to federally legalize marijuana on the House floor in 2022. She did, however, support separate legislation in 2021 to ease the cannabis industry’s access to banking services. Meanwhile in Iowa, Democratic gubernatorial candidate Rob Sand recently explained why he thinks marijuana should be legalized and treated like alcohol, even if he thinks it’s “dangerous.” “Marijuana is a dangerous drug,” he said. “You shouldn’t abuse it, but we also shouldn’t throw people in prison just for using it. We should treat it the way we treat alcohol. Alcohol is a dangerous drug. You shouldn’t abuse it, but we don’t throw you in prison just for having a beer when you get home.” Separately, Iowa regulators are circulating proposed rules changes to remove the residency requirement for patients in the state’s medical cannabis program while also ensuring that military veterans qualify for reduced registration fees. The residency-focused part of the regulatory change from the state Department of Health and Human Services is meant to comply with provisions of a bill that Gov. Kim Reynolds (R) signed into law in June. In addition to allowing out-of-state residents to register in the medical cannabis program if they have a certification from an Iowa healthcare provider legislation, that legislation also doubles the number of medical cannabis dispensaries that are allowed to operate in the state. Also this session, Iowa lawmakers considered a bill to create a state-regulated therapeutic psilocybin program for patients with post-traumatic stress disorder (PTSD). Last year, the governor vetoed earlier legislation that would have allowed doctors in the state to immediately prescribe a synthetic form of psilocybin in the event of federal approval of the psychedelic substance by the U.S. Food and Drug Administration (FDA), arguing that it “surrenders state authority to make an informed determination about classification to federal officials.” The post Marijuana Should Be Federally Legalized And Taxed, U.S. Senate Candidate Josh Turek Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Advocates for convenience stores are celebrating a recently enacted delay in the effective date of a federal ban on hemp THC products, saying the move provides an opportunity to create regulations as an alternative to prohibition. Convenience stores, they say, are an ideal place to continue to sell hemp products under any new rules that are enacted “The convenience retail channel, with its well-established age verification procedures, is suited to selling hemp products to adults legally and responsibly,” Jon Taets, director of government relations for NACS, formerly the National Association of Convenience Stores, said. “We look forward to working with Congress on a solution that not only protects children in our communities but also supports small businesses,” he said. The group has “actively encouraged Congress to delay the hemp ban,” NACS said. “Doing so provides more time to develop a regulatory framework that allows for legal, safe sales of products containing hemp-derived THC to adults.” “These products are an important category for convenience stores, which have experienced significant demand for THC beverages and other products from adult customers,” the organization said. “For c-store operators, the hemp-derived THC category could offer significant sales and growth opportunities, particularly in states that have passed legislation to regulate these products.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12. Now, however, under provisions included in a funding bill Trump signed last week, the effective date of the ban for most products is being pushed back to December 11 to give lawmakers more time to craft regulations for hemp derivatives. There is a carve-out, however, to allow the recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Melissa VonderHaar, the vide president of commercial strategy for iSee Store Innovations and chair of the C-Store Cannabis Board for CSP, said that the delay in the ban is “very important” but is “only step 1.” “Retailers, now is the time to make some noise. Convenience sees more customers per day than any other channel,” she said in a social media post. “Get the signage up, leverage your loyalty apps to make sure your shoppers know: the ban is still coming and their voices matter. The write-in campaigns depend on VOLUME and our channel is uniquely equipped to deliver.” VonderHaar told CSP that “this extension demonstrates what can be accomplished when the right partners work together toward a common goal.” “Now, we need to build on that momentum and unify behind a regulatory framework we can get across the finish line by December,” she said. Now that Trump has signed the delay of the ban into law, members of Congress are debating how—and whether—the crop’s derivatives should be regulated as an alternative to prohibition. Several Republican lawmakers spoke to Marijuana Moment last week about the kinds of rules they would like to see enacted to keep hemp THC products legal. A number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products. Until now, none of those proposals have gained traction with congressional leaders. For example, Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) filed a bill to keep hemp THC drinks legal while taxing and regulating them like alcohol. Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Trump and White House officials repeatedly pressed Congress to delay, alter or reverse the ban in recent months. In a letter to House Speaker Mike Johnson (R-LA) in June, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said in June, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” Some members of the alcohol industry have also urged Congress to regulate, rather than ban, hemp products. The National Restaurant Association recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The post Convenience Store Industry Says Congress Should Regulate Hemp THC Products Instead Of Banning Them appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A new report from congressional researchers says that a split among circuit courts about whether state marijuana business licensing systems can discriminate against out-of-state residents “likely increases the odds” that the Supreme Court will take up and resolve the issue. The Congressional Research Service (CRS) report, published on Thursday, examines the Dormant Commerce Clause of the U.S. Constitution, which has been interpreted by the Supreme Court to bar protectionist state laws that unduly restrict interstate commerce even in areas where Congress has not directly weighed in. As more states have legalized marijuana, some have enacted policies that favor business run by in-state residents over those led by people based in other states. Some of those polices have been challenged with federal lawsuits, and appeals courts have reached different conclusions about the issue. The U.S. Court of Appeals for the for the Second Circuit, for example, ruled that a New York policy that prioritizes licensing for cannabis businesses run by people who have been convicted of marijuana-related charges under that state’s laws, or have a relative with such a conviction, likely violates the Dormant Commerce Clause. “The Commerce Clause prohibits the enforcement of state laws driven by economic protectionism—that is, regulatory measures designed to benefit in-state economic interests by burdening out-of-state competitors,” the court ruled. CRS noted in its analysis that the court acknowledged “the irony behind applying this objective to federally illegal marijuana markets” but said that the Supreme Court previously determined in a medical cannabis case, Gonzales v. Raich, that the illegal nature of marijuana activities “is of no constitutional import” for purposes of the Commerce Clause. The U.S. Court of Appeals for the First Circuit, for its part, held that a Maine law requiring all officers and directors of a marijuana business to be residents of the state violates the Dormant Commerce Clause. State officials in the case didn’t dispute that the state law would violate the Dormant Commerce Clause if marijuana were federally legal, but instead argued that the state statute is permissible “because federal law makes participation in the market to which the residency requirement applies illegal.” They argued that the Dormant Commerce Clause only bars states from “unjustifiably…discriminat[ing] against or burden[ing] the interstate flow of articles of commerce,” whereas there can’t be an interstate commercial market federally illegal cannabis. The court disagreed, reasoning that the Supreme Court’s Raich ruling determined that marijuana is “a fungible commodity for which there is an established, albeit illegal, interstate market.” The U.S. Court of Appeals for the Ninth Circuit, on the other hand, declined to apply the Dormant Commerce Clause to challenges to marijuana business ownership residency requirements in Washington State and Sacramento, California. The court cited Supreme Court guidance to “tread cautiously when considering whether to invalidate state laws under the court inferred dormant Commerce Clause,” ultimately reasoning that there is no “implied constitutional right to engage in illegal interstate commerce.” “Nothing in dormant Commerce Clause precedent requires us to indulge the obvious ‘irony’ of applying a doctrine implied from an affirmative grant of power to Congress to preserve a national market that Congress does not want to exist,” the Ninth Circuit opinion said. CRS said that although the Supreme Court has not yet agreed to take up the application of the Dormant Commerce Clause to such marijuana business licensing disputes, the split in views on the issue among circuit courts “likely increases the odds that the Court will review this issue at some point.” “The fact that all the cases discussed above were decided when all relevant state marijuana activities remained illegal under federal law, however, might make the Court less likely to grant certiorari,” the report said. The justices may instead “wait to see how future lower court Dormant Commerce Clause analysis in this space evolves” in light of the Trump administration’s move to federally reschedule marijuana, CRS reasoned. Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III. Under a separate order he signed, a Drug Enforcement Administration (DEA) hearing was held to consider more comprehensively moving marijuana to Schedule III. In any case, CRS said, lawmakers don’t need to wait for courts to weigh in. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — “Congress has the power to address the issue itself,” the report said. “As the Supreme Court has explained, ‘Congress has undoubted power to…either permit the states to regulate the commerce in a manner which would otherwise not be permissible or exclude state regulation.'” “Congress could thus pass legislation providing states and localities an ‘unmistakably clear’ authorization to implement protectionist marijuana policies,” CRS said. It could also “do the opposite and expressly bar states and localities from implementing marijuana-related laws that favor in-state residents over nonresidents,” the report noted. “Similarly, Congress could establish a federal regulatory system applicable to marijuana activities that fits more closely within the Supreme Court’s existing Dormant Commerce Clause jurisprudence, as opposed to the current status where the Court has never weighed in on how the Clause applies to activities that are illegal under federal law,” CRS concluded. The Marijuana Policy Project, a pro-legalization advocacy group, recently said that it believes there could soon be a “successful” federal lawsuit concerning the Dormant Commerce Clause’s applicability to interstate cannabis commerce in light of rescheduling. “DCC protection would bar states with legal markets from discriminating against legal products from other states,” MPP said. “The federal decisions finding no DCC protection have leaned on cannabis’s federal illegality.” The move to reschedule cannabis “almost certainly changes that for licensed medical operators,” the group said. “We expect stakeholders to sue states in multiple federal circuits (hoping to consolidate those into one suit), seeking to force open state markets on constitutional grounds,” MPP said.” Interstate commerce in Schedule III drugs between DEA-approved entities is clearly covered by the DCC. A federal case will take time, but assuming rescheduling stands, we expect federal litigation to be ultimately successful.” The post Supreme Court Could Resolve Marijuana Business Licensing Disputes, Congressional Report Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Using marijuana appears to have a “positive outcome” on people struggling with some eating disorders, according to a new study. “Cannabis is widely used by people with eating disorders and is widely perceived as beneficial in restrictive and food-averse, but not binge, eating disorder subtypes,” the paper, published in the Journal of Eating Disorders, found. Researchers at the University of Sydney in Australia surveyed more than 7,500 people with a diagnosed or self-reported eating disorder (ED), with more than 3,o00 of whom that used cannabis within the past year. Respondents represented 76 countries, with most residing in Australia (29.7 percent), the United Kingdom (21.7 percent) and the United States (17.6 percent). “Cannabis received the highest mean ratings of any drug for improving ED symptoms” among people avoidant/restrictive food intake disorder, anorexia nervosa and other specified feeding and eating disorder, the study found. People with unspecified feeding or eating disorder “also reported a favorable rating.” For people with anorexia nervosa specifically, “cannabis use drove reductions in food-related anxiety and guilt, which, together with appetite stimulation, helped normalise their eating,” the study found. “The gastroprotective and antinausea properties of cannabis appear to provide additional therapeutic benefits over and above those provided by appetite stimulation and anxiety reduction.” For people with avoidant/restrictive food intake disorder (ARFID), which involves a lack of desire to eat and aversions to food based on sensory factors such as texture, taste and smell, there is a “transformational effect of cannabis” related to “increased appetite and enhanced ability to recognise hunger cues,” the researchers wrote. “The higher frequency of daily cannabis use amongst those with ARFID may well reflect self-medication for these therapeutic benefits,” they said. “Indeed, daily use of cannabis flower was generally associated with higher ED symptom improvement scores relative to intermittent use, suggesting that symptom improvement may drive frequency of use.” In contrast, people with binge eating disorder and bulimia nervosa, “provided lower ratings” for marijuana’s efficacy—perhaps because “the appetite-stimulating properties of THC may exacerbate binge/purge symptomatology,” the paper said. When participants were prompted with open-ended questions, “general mental health was self-reported as improved by cannabis in most respondents regardless of diagnosis,” the researchers wrote. Participants also said cannabis helps with improved ability to eat, improved awareness of hunger cues, reduced guilt related to their eating disorder, less nausea and diminished food-related anxiety. “Our findings suggest that cannabis is widely used by individuals with an ED or disordered eating and that naturalistic use of cannabis is self-reported as having a positive outcome on ED symptoms.” That said, “a substantial number described mixed experiences of both improvement and exacerbation of ED symptoms,” the study found. The research is a follow-up to an earlier paper that some of the same authors published in the Journal of the American Medical Association that found that marijuana and psychedelics were “the highest rated” drugs in effectively addressing eating disorder symptoms. “Our top-level analysis indicated that cannabis was commonly used among respondents and was one of the few drugs rated positively for ED symptom improvement. In [anorexia nervosa], [avoidant/restrictive food intake disorder,], and [other specified deeding and eating disorder], this positive rating was superior to all prescription drugs.” While daily use of marijuana flower specifically was more associated with improved eating disorder scores than intermittent use in the new study, symptom improvement didn’t vary overall based on cannabis product type or cannabinoid composition. The researchers noted that the self-report and naturalistic nature of the study means that no strong causal conclusions can be drawn, saying that “future clinical trials of cannabis products are warranted in eating disorders.” They also flagged concerns about cannabis dependence and “other adverse effects” of frequent use that some participants reported. The post Marijuana Improves Symptoms For People With Anorexia And Other Eating Disorders, Study Finds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I just concept it will be an example to write incase everyone else was basically experiencing difficulity considering and yet I'm sure a little bit of suspicious considerably more than simply morning allowed to position manufacturers not to mention talks about concerning in this case. toto

GOP lawmakers talk hemp regulations; NH legalization push; TX Dem campaigns on marijuana; NE medical cannabis laws upheld Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW President Donald Trump commuted the sentences of more people with marijuana convictions as his administration continues to consider federal cannabis rescheduling. Several Republican members of Congress spoke to Marijuana Moment about their views on how—and whether—hemp THC products should be regulated now that President Donald Trump signed a bill to delay a scheduled ban for one month. New Hampshire Democratic gubernatorial candidate Cinde Warmington said the state should legalize marijuana and stop sending tax revenue to its neighbors that have already enacted the reform. Texas Democratic lieutenant governor candidate Vikki Goodwin is campaigning on her support for cannabis reform—hosting a “Legalize It” rally, endorsing a local Houston ballot initiative to deprioritize marijuana arrests and bashing Lt. Gov. Dan Patrick (R) for championing a hemp THC product ban. The Nebraska Supreme Court unanimously upheld voter-approved medical cannabis legalization ballot initiatives, rejecting litigation from Republican elected officials who sought to invalidate them. North Carolina’s state health director said he is “not in any way convinced that we are definitely moving to be a marijuana-legal state” but that “it could happen.” Mike Simpson of Lovewell Farms argues in a new op-ed that Rhode Island attorney general candidates should explain whether they intend to defend the state’s decision to regulate hemp in the face of federal uncertainty. / FEDERAL The Food and Drug Administration issued a request for information on opportunities to advance the development of botanical drug products. Rep. Pete Sessions (R-TX) discussed his support for recriminalizing hemp THC products. Nebraska independent Senate candidate Dan Osborn tweeted, “Nebraskans voted for medical marijuana, yet Pete Ricketts has done everything he can to OBSTRUCT it. Today, the Nebraska Supreme Court said NO. This is bigger than medical marijuana, it’s about the power of our vote. Politicians work for us. And today, our Supreme Court reinforced that truth and upheld the power of the people.” / STATES North Dakota Gov. Kelly Armstrong (R) signed a bill to ban synthetic kratom products and limit sales of kratom to adults over the age of 21. California Gov. Gavin Newsom (D) tweeted, “Legal cannabis sales have generated nearly $8.4 BILLION in tax revenue for California communities, funding programs like: → Childcare and early childhood development → Youth substance abuse prevention → Medical research → Environmental recovery” Rhode Island Democratic attorney general candidates clashed over the record of one contender as chair of the state Cannabis Control Commission. Montana regulators adopted changes to rules marijuana business security requirements and correspondence standards. Florida regulators are proposing stricter marketing rules for medical cannabis. The New Jersey Cannabis Regulatory Commission will meet on Wednesday. The New York Cannabis Advisory Board will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Houston, Texas misdemeanor marijuana arrests have increased by nearly 1,300 percent under the current mayor. Los Angeles, California regulators sent a newsletter with various cannabis updates. / INTERNATIONAL The UK Food Standards Agency is preparing to recommend approval of CBD oils, sweets, drinks and supplements. New Zealand officials gave approval to two psychiatrists to prescribe MDMA to people with PTSD. / SCIENCE & HEALTH A review concluded that “cannabinoids exhibit biologically plausible antitumour activity across multiple cancer hallmarks and may present promising candidates for combination therapeutic strategies.” A review concluded that ayahuasca “is a promising therapeutic intervention in neuropsychiatric disorders.” / ADVOCACY, OPINION & ANALYSIS The chair of the Florida Democratic Party tweeted, “72% of Floridians voted for access to medical cannabis and almost 1 million Floridians (including my dying father and saved my mother’s life) are patients, but Desantis has been hellbent on destroying the program. Thank god only 123 more days of this a**hole.” The Miami Herald editorial board said voters deserve a “do-over” on a marijuana legalization ballot measure that narrowly failed after state officials used Medicaid funds to campaign against it. Americans for Safe Access published a guide about medical cannabis patients’ rights under federal rescheduling. / BUSINESS The University of Maryland sent a cease and desist letter to Terps USA over alleged trademark infringement. / CULTURE Tennis player Aryna Sabalenka halted a U.S. Open match over the smell of marijuana. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Trump releases federal cannabis prisoners (Newsletter: September 7, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Finding trustworthy company near Naraina used to be difficult. Our call girls service near by Sarovar Portico Hotel changed that. We carefully select women who are elegant, willing, and reliable. They understand the need for discretion in hotel settings. They arrive dressed appropriately and behave impeccably. Your identity never leaks. No advance payment. Contact our team. Available all night. Experience the quality our clients consistently praise.

Thanks, that was a really cool read! olxtoto alternatif

You've checked into Hyatt Regency Hotel in Bhikaji Cama Place and the evening stretches ahead — empty and boring. We can fix that. Our Hyatt Regency Hotel Escorts Service is here to turn your ordinary evening into something special. Our girls are fun, friendly, and know how to keep you entertained. Whether you want to go out for dinner, have a drink, or just relax in your room, they're up for it. With verified profiles, cash on delivery, and quick service, we make sure you have a great time. Call us now and let the fun begin.

So luck to come across your excellent blog. Your blog brings me a great deal of fun.. Good luck with the site. 公司秘書

“Rhode Island has already chosen to regulate hemp rather than prohibit it. Our next attorney general should explain whether they intend to defend that decision.” By Mike Simpson, Lovewell Farms via Rhode Island Current Last October, Rhode Island Attorney General Peter Neronha (D) joined 38 other state attorneys general in signing a letter urging Congress to change the federal definition of hemp. On August 4, Neronha signed another multistate letter, this time urging Congress to reject any effort to “delay, repeal, suspend, or weaken” hemp restrictions enacted in November 2025. I have now written twice in the last year about the problems with this federal policy and its consequences for Rhode Island farmers and small businesses. I write as the co-founder of Lovewell Farms, Rhode Island’s only USDA-certified organic hemp farm, founded in 2018. I write this with nearly 20 years experience in cannabis and drug policy. Lovewell Farms supports strong regulation of hemp products, including testing, reasonable potency limits, child-resistant packaging, accurate labeling and restrictions on sales to minors. What we do not support is describing Rhode Island’s regulated hemp industry as something that is harmful. That was one of the central problems with the October 2025 attorneys general letter. It described a national hemp market in which products are sold “without consistent age restrictions, labeling standards, or safety requirements,” while discussing gummies and beverages marketed to children and synthetic cannabinoids produced through chemical conversion. Those concerns may be legitimate in states that have failed to regulate hemp products. They do not accurately describe Rhode Island. Neronha signing this letter made it appear he agreed with these claims, and that they were reflective of our state’s program. But Rhode Island has a state-regulated hemp program. Businesses like mine operate under state licenses and are subject to the exact same requirements governing testing, potency, labeling, packaging and age restrictions as the state’s medicinal cannabis program. The state has also placed specific limits on THC in consumable hemp products. There is certainly room to debate whether those regulations should change, but it is simply inaccurate to describe Rhode Island’s hemp market as unregulated and unsafe. This distinction became particularly important after Congress enacted a new federal definition of hemp last November. Rhode Island Sens. Jack Reed (D) and Sheldon Whitehouse (D) both opposed an amendment that would have removed the hemp provision, and their offices subsequently told Rhode Island Current that they did so “at the urging of the vast majority of the state attorneys general.” Neronha’s participation in the October letter therefore had consequences beyond Rhode Island. It provided the justification for a congressional vote that now threatens farmers nationwide. This August letter is more troubling after the U.S. House of Representatives on Tuesday passed legislation that would give farmers another month before the new definition takes effect. The provision is part of a short-term government funding bill to avoid a federal shutdown this fall. It keeps the federal government funded through December 11 and was already approved by the Senate in early August. If signed into law by President Donald Trump, the effective date of the hemp product ban would also be moved to December 11. Rather than support that effort, Neronha joined other attorneys general in asking Congress to reject any delay or modification. The problem remains that the federal definition is much broader than the synthetic and highly intoxicating products discussed throughout both letters. The August letter itself acknowledges that the new law excludes final hemp-derived cannabinoid products containing more than 0.4 milligrams of total THC per container. That threshold does not merely eliminate synthetic delta-8 products or high-potency THC gummies. It threatens ordinary, naturally extracted, full-spectrum CBD products containing trace amounts of THC like those manufactured on our farm. This is important for farmers like me. CBD-rich hemp flower plants naturally produce small amounts of THC. Full-spectrum extracts preserve most of the natural cannabinoids in the plant. Our products can therefore be non-intoxicating, produced without chemical conversion, and compliant with state law, all while containing more than 0.4 milligrams of THC per package. The August letter nevertheless states that the new definition will preserve “safe, nonintoxicating hemp products” and “will not inhibit the cultivation of hemp.” For cannabinoid hemp farmers, those assertions deserve considerably more scrutiny. Congress should be able to prohibit synthetic intoxicants or establish reasonable national standards without defining naturally occurring, non-intoxicating full-spectrum CBD products out of existence. AG candidates: Please answer the following This issue now has particular relevance in Rhode Island because Neronha is term-limited. The state will elect a new attorney general this year, and that person will inherit the authority to sign letters like these on Rhode Island’s behalf. The candidates for attorney general should therefore explain their positions on hemp before the primary election. Do you support Rhode Island’s existing regulated hemp industry? Do you believe naturally occurring full-spectrum CBD products should remain legal? Do you support the federal 0.4-milligram-per-container standard, even when it prohibits non-intoxicating products that are legal under state law? Do you support distinguishing those products from chemically converted intoxicating cannabinoids? Will you consult Rhode Island regulators, farmers and licensed businesses before signing national policy letters that make factual claims about our state? When an attorney general signs such a letter, the signature carries the authority of the state. As the congressional response to the October letter demonstrated, those signatures can influence federal policy. The August letter suggests that there is still a substantial disconnect between the national hemp debate and the businesses operating under Rhode Island law. Do you support the federal 0.4-mg-per-container standard, even when it prohibits non-intoxicating products that are legal under state law? Will you consult RI regulators, farmers, & businesses before signing national policy letters that make factual claims about our state? — Lovewell Farms (@lovewell_farms) September 2, 2026 The next attorney general has an opportunity to approach this differently. Rhode Island does not need someone who automatically agrees with the hemp industry, nor should the industry be exempt from scrutiny. We need an attorney general who understands the laws already in place and distinguishes between regulated and unregulated markets, intoxicating and non-intoxicating products and synthetic cannabinoids and the naturally occurring compounds found in a legal agricultural crop. Rhode Island has already chosen to regulate hemp rather than prohibit it. Our next attorney general should explain whether they intend to defend that decision, or abandon it. Mike Simpson is the co-founder of Lovewell Farms, Rhode Island’s only U.S. Department of Agriculture (USDA) organic hemp farm. He is also a historian, educator and longtime advocate for policy reform. He was previously deputy director for Regulate Rhode Island and an initiative coordinator for Marijuana Policy Project in Maine. He now lives in Providence and farms in the village of Hope Valley in Hopkinton. This story was first published by Rhode Island Current. The post Rhode Island Hemp Farmer Wants Attorney General Candidates To Answer These Questions (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Superbly written article, if only all bloggers offered the same content as you, the internet would be a far better place 먹튀검증 커뮤니티

Dodging trees and timing jumps in Snow Rider 3D makes staying focused part of the fun. We feature it on OzoGames, where you can play directly in your browser without downloads.

“We are not in any way convinced that we are definitely moving to be a marijuana-legal state. It could happen, but it may not.” By Clayton Henkel, NC Newsline When members of the North Carolina House and Senate reconvene in November, they will be faced with having to decide how to regulate intoxicating hemp products. The two chambers were at odds in July over House Bill 328, which would ban hemp with more than 0.4 milligrams of THC and prohibit the sale of any hemp consumables, including CBD, to anyone under 21. House members opted to wait until after November’s midterm elections, not wanting to upset a $4 billion industry that employs 16,000 people in North Carolina. In Washington, the hemp industry received a one-month reprieve this week from a national ban on intoxicating hemp products as part of a short-term funding bill. The U.S. House voted to delay the ban from taking effect until December 11, as the White House pushes to delay or somehow fix the national ban. At the same time, the Trump administration has called on the U.S. Department of Justice to reclassify marijuana as a Schedule III drug, the same class as Tylenol with codeine. While the outlook is hazy, the end of the year could bring big changes for both the hemp and cannabis industries. Hemp consumables are largely unrestricted in our state, but North Carolina is in the unique minority of states in which marijuana is fully illegal for both recreational and medicinal purposes. State lawmakers are trying to navigate how to best protect minors from hemp-derived cannabinoids, while also preparing for a future that could include some form of legal cannabis. 39 states, 39 approaches The North Carolina Advisory Council on Cannabis, appointed in June 2025 by Gov. Josh Stein (D), has been meeting for months to develop a comprehensive approach to regulate cannabis sales and create a safe, legal market for adults that protects kids. Nearly 40 states have already enacted cannabis regulations, but no two are the same. Yasha Kahn, co-founder of MCR Labs, has been involved in cannabis testing for more than a decade. Kahn was invited to offer his expertise to the advisory council last week, as that group explores a framework for legalization. North Carolina policymakers will have to decide on an endless number of variables in regulating cannabis, including who should handle testing and at what point in the process the product should be tested. Kahn said each state has unique testing requirements with no real consensus. And each state may have its own approach to testing batch sizes, packaging, total THC definitions, and regulatory audits. “Instead of looking at this as a huge mess, it really is 39 individual experiments on policy with much of the data available that we can analyze,” said Kahn. “We can see which policies have worked, which ones haven’t.” Kahn said cannabis has the potential to be a multi-billion-dollar industry for North Carolina. Balancing testing and oversight The advisory committee will also have to decide whether to use private labs or state labs to test the purity and potency of cannabis if it should become legal. Either way, Kahn recommended the state should require all lab results be made public and shared with state agencies. “How long would it take to have a testing lab to be up and running and producing results?” asked council member Pat Oglesby. Kahn said there are hemp labs that would likely be willing to take on the testing for a slice of a booming industry, but establishing an accredited lab from scratch would take time. “A lot of instruments have months of delays just to be delivered. You have to have capital and good talent,” said Kahn. “I’ve heard of labs opening within maybe nine months. In my experience, it’s closer to a year and a half.” Privatizing testing, however, comes with risk, Kahn said, as consumer fraud has been documented in multiple states. A store owner, for example, may find a low THC product is not selling well and urge the cultivator to produce a stronger product. The cultivator may then call the lab and suggest they provide higher THC results, or they will find a new lab to deliver those results. “This happens in every market that has more than one lab,” Kahn cautioned. Kahn said this deception becomes easier to trace when the labs are required to share data with the state and those results are made public. In Colorado, THC potency inflation and the failure to identify mold and other contaminants has legislators considering shifting their cannabis testing to the Colorado Department of Public Health and Environment. Lawmakers there are also considering having state regulators collect the samples to be tested from dispensaries, rather than samples being provided by the producer or cultivators. Will the industry bloom in North Carolina? Dr. Larry Greenblatt, state health director and co-chair of the advisory council, said while it may appear that North Carolina is marching toward some form of cannabis legalization, it’s by no means a foregone conclusion. “We are not in any way convinced that we are definitely moving to be a marijuana-legal state,” said Greenblatt. “It could happen, but it may not.” The advisory group’s final recommendations, including a detailed look at lab testing, will be included in a report to the governor at the end of this year. It would then be up to the legislature to decide if they want to use the information as the foundation or guidance for a cannabis market in North Carolina. Stein has said he supports legalization for adults, but Republican lawmakers are divided. Recent attempts to legalize medical marijuana have died in the state House, despite the backing of Senate leaders. And neither chamber has ever voted to legalize the drug for recreational use. Meantime, other states are moving ahead. In neighboring Virginia, regulators will begin accepting applications for regulated recreational cannabis dispensaries in February, with a retail launch set for July 1, 2027. This story was first published by NC Newsline. Photo courtesy of Brian Shamblen. The post North Carolina Officials Weigh Marijuana And Hemp Policies As Federal Law Remains In Flux appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Fantastic submit, Many thanks regarding revealing This kind of information. Fantasticly composed write-up, only if almost all people supplied the identical amount of articles when you, the net would have been a greater spot. You should keep writing! Prop firm ea mt5

Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking. GAJIAN 123

This is the details My business is locating everywhere you go. Appreciate it on your blog site, I just now signed up your site. That is a pleasant blog site. inch. slot

Business travelers staying for two or three nights rarely want to travel across the city. Guests looking for Escorts Near JRD Luxury Boutique Hotel Safdarjung Enclave appreciate that the options available stay close enough to make the evening simple rather than a logistical exercise.

Delhi is a city of dreams, and we're here to make sure your fantasies become reality. Our Delhi Escorts Service brings you the finest selection of call girls who are ready to stay with you the whole night. These women are not just beautiful—they are intelligent, fun-loving, and know how to make every moment memorable. Whether you're looking for a romantic dinner date, a party partner, or a passionate night, they are perfect for any occasion. With affordable rates and verified profiles, we make it easy to find your dream companion.

Thanks for your time designed for advertisment a great very good guide! I noticed your internet-site ideal for a must have. It has splendid and even effective content articles. Compete the best get the job done! situs toto

President Donald Trump has granted clemency to two people who are serving time for federal marijuana convictions as his administration advances the process of rescheduling cannabis. The president on Thursday commuted the sentences of Jerry Haymon IV and Kevin Harden, effectively ending their sentences and putting them on the path to being free. Haymon was given a 10-year mandatory minimum sentence in federal prison for his participation in a marijuana distribution conspiracy, and has been living in home confinement for the past year. Until now, he has had about a year left to go and has experienced difficulty getting approval for jobs. For example, the private company overseeing his home confinement blocked his ability to handle social media for a cannabis company and to do research at a policy organization that touched on the issue of marijuana even though neither job would have involved him touching the plant. “Today is an amazing day that I will never forget,” Haymon told Marijuana Moment on Friday after receiving the news of his commutation, saying it feels like he has been “reborn again.” “I got my life back,” he said. “There are no words that can fully express what this act of clemency means to me and the people I love. I am deeply grateful to everyone who advocated for me, supported me and helped give me this second chance.” Thirty-six members of Congress sent a letter to then-President Joe Biden in support of Haymon’s request for clemency. “Jerry was a two-way football star in high school who went on to play defensive back in college, where he was majoring in economics (and even made the Dean’s List one semester),” the lawmakers wrote. “Prior to his arrest in 2017, Jerry was looking to try out for professional football. At sentencing, the trial judge regretfully noted that his hands were tied by federal mandatory minimum prison terms for marijuana.” While Biden issued mass pardons to people who committed federal marijuana possession offenses, he did not heed calls to free people serving time in federal prison for involvement in selling cannabis. Harden, the other person that Trump granted clemency to on Thursday, has been serving a 30-year sentence after being convicted of conspiracy to distribute marijuana. His co-defendant in the cannabis case, James Romans, was granted clemency by Trump in 2021 on the final day of his first term in office. While incarcerated, Harden has experienced several severe medical issues, including multiple open-heart surgeries, a seizure disorder and blood-clotting. The clemency applications from Haymon and Harden were both accompanied by a letter that boxer Mike Tyson wrote to Trump in which he praised the president for making moves to federally reschedule marijuana. “There are Americans still sitting in federal prison for the very conduct your order addresses, waiting to see if your historic words will extend to them,” he wrote. “With two-thirds of Americans in support of marijuana legalization, not more punishment, the politics align with common sense policy. Yet individuals remain behind bars under outdated federal laws for conduct that today would not result in prison in much of the country.” “Granting clemency to non-violent marijuana offenders would reunite families, restore lost opportunity, and write the final chapter of the federal war on marijuana—a chapter that only you have the power to close,” Tyson said. “It would be a legacy moment: bold, decisive, and right. I respectfully urge you to act.” The two cannabis commutations are part of a broader package of clemency grants the the president issued this week. Trump’s move to free a handful of cannabis prisoners comes as his administration of moving forward with the process of federally rescheduling marijuana. Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III. Under a separate order he signed, the DEA hearing was held to consider more comprehensively moving marijuana to Schedule III. An agency judge is currently considering a recommendation on the issue, and then the DEA administrator will issue a final determination. During the hearing, DEA officials charged with defending the cannabis rescheduling proposal highlighted testimony on marijuana’s medical benefits and its relative safety compared to other substances such as alcohol and opioids. That included appearances from a Food and Drug Administration (FDA) scientist and a medical doctor from New Hampshire who detailed how medical marijuana provides relief to pain patients and can serve as an alternative to opioids. Weldon Angelos, founder of the criminal justice non-profit The Weldon Project who received a cannabis-related presidential pardon during Trump’s first term, said that “today is an extraordinary day for two deserving men and their families.” “These grants of clemency are about mercy, redemption, second chances and recognizing the humanity in people who have already paid an enormous price for their mistakes,” he said. “President Trump has granted clemency to two individuals serving prison time for cannabis, Jerry Haymon and Kevin Harden. Jerry, a former college football standout, has worked incredibly hard to demonstrate that a person’s worst moment should never define the rest of their life. Kevin has endured serious and debilitating medical conditions that have made his continued incarceration both extraordinarily difficult and increasingly dangerous.” “I am deeply grateful to President Trump and Alice Johnson for continuing to give deserving people a pathway home,” Angelos said, referring to Trump’s White House pardon czar who herself received clemency from Trump in 2018. “For Jerry and Kevin, and especially for the families who have waited and prayed for this day, this is life-changing,” he said. “We are also encouraged by the administration’s continued commitment to clemency and expect to see more deserving individuals receive relief in the future. This is exactly why we do this work.” Haymon said he is “eternally grateful to President Donald J. Trump and Alice Johnson for granting me a full commutation for my marijuana offense and giving me the opportunity to move forward with my life without this conviction hanging over me.” “I also want to thank Weldon Angelos and the entire Mission Green and Weldon Project team for believing in me, fighting for me, and never giving up on my case,” he said. “They stood beside me and my family throughout this process and worked tirelessly to make this moment possible.” Erik Luna, who represented Haymon on behalf of the Mission Green Initiative and serves as director of research and legal policy at the Weldon Project, said his client “received a ten-year federal sentence for conduct that is now legal in both states where the offense occurred.” “Jerry served years in prison for a first-time, nonviolent marijuana offense, while today multi-billion-dollar cannabis companies operate openly under state law—often with armed security—engaging in the very conduct for which Jerry was convicted and sentenced,” he said. “That is the definition of injustice.” Earlier this year, Trump pardoned a former NFL star who was convicted of trafficking 175 pounds of marijuana. At the start of his second term, the president fulfilled a campaign promise by commuting the life sentence of Ross Ulbricht, a man who was convicted of running a dark web illicit drug market. The post Trump Releases More Federal Marijuana Prisoners As DEA Considers Rescheduling Cannabis appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net